LYONASE

Welcome to the Brand page for “LYONASE”, which is offered here for Pharmaceuticals and therapeutics for the prevention and treatment of diseases and disorders of the audiovisual systems, cardiovascular systems, central nervous systems, digestive systems, endocrinologic systems, gastroenterologic systems, genito-urinary systems, hematology, mental and psychologic functioning, musculo-skeletal systems, nepbrologic systems, ophthalmologic systems, respiratory system, sensory systems, and skin and body tissues, and for the treatment of pain; pharmaceutical powder bases for the delivery of medications; inhalers, nasal sprays and injectors filled with pharmaceutical preparations for prevention and treatment of diseases and disorders of the audiovisual systems, cardiovascular systems, central nervous systems, digestive systems, endocrinologic systems, gastroenterologic systems, genito-urinary systems, hematology, mental and psychologic functioning, musculo-skeletal systems, nephrologic systems, ophthalmologic systems, respiratory system, sensory systems, and skin and body tissues, and for the treatment of pain;inhalers, nasal sprays and injectors for therapeutic use, sold empty; medical apparatus in the nature of aerosol dispensers for drug delivery of powder-based drugs to body cavities, sold empty; medical apparatus in the nature of aerosol dispensers for drug delivery of powder-based drugs to the lungs, sold empty;.

Its status is currently believed to be active. Its class is unavailable. “LYONASE” is believed to be currently owned by “BRITANNIA PHARMACEUTICALS LIMITED”.